Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation.
Novartis
Novartis
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Amgen
Therapeutic Advances in Childhood Leukemia Consortium
M.D. Anderson Cancer Center
Novartis
Rutgers, The State University of New Jersey
Therapeutic Advances in Childhood Leukemia Consortium
Fred Hutchinson Cancer Center
Amgen Research (Munich) GmbH
M.D. Anderson Cancer Center
Amgen Research (Munich) GmbH
M.D. Anderson Cancer Center